Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.917
+0.037 (4.16%)
At close: Feb 27, 2026, 4:00 PM EST
0.884
-0.033 (-3.60%)
After-hours: Feb 27, 2026, 7:48 PM EST
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $6.41 million as of February 27, 2026. Its market cap has decreased by -65.61% in one year.
Market Cap
6.41M
Enterprise Value
-7.31M
1-Year Change
-65.61%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $6.41M, a decrease of -66.14%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 6.41M | 7.47% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 7.12M |
| Alaunos Therapeutics | 6.99M |
| XTL Biopharmaceuticals | 6.74M |
| Revelation Biosciences | 6.69M |
| Aptorum Group | 6.42M |
| Creative Medical Technology Holdings | 6.36M |
| Purple Biotech | 6.01M |
| Calidi Biotherapeutics | 6.00M |